Susquehanna International Group, LLP Madrigal Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 18,207 shares of MDGL stock, worth $5.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,207

Previous 4,814 278.21%

Holding current value

$5.62 Million

Previous $1.35 Million 186.57%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $2.84 Million - $3.92 Million	13,393 Added 278.21%	18,207 $3.86 Million
Q2 2024 Aug 15, 2024	SELL	$193.33 - $291.99 $1.11 Million - $1.68 Million	-5,746 Reduced 54.41%	4,814 $1.35 Million
Q1 2024 May 07, 2024	SELL	$171.37 - $283.23 $8.95 Million - $14.8 Million	-52,213 Reduced 83.18%	10,560 $2.82 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $2.25 Million - $4.42 Million	18,654 Added 42.28%	62,773 $14.5 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $2.09 Million - $3.22 Million	-14,279 Reduced 24.45%	44,119 $6.44 Million
Q2 2023 Aug 11, 2023	SELL	$203.88 - $312.0 $14.4 Million - $22 Million	-70,560 Reduced 54.72%	58,398 $13.5 Million
Q1 2023 May 16, 2023	BUY	$231.06 - $307.08 $27.2 Million - $36.2 Million	117,894 Added 1065.56%	128,958 $31.2 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $646,552 - $3.28 Million	-11,073 Reduced 50.02%	11,064 $3.21 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $1.34 Million - $1.76 Million	22,137 New	22,137 $1.44 Million
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $1.63 Million - $2.98 Million	-29,231 Reduced 56.67%	22,350 $2.19 Million
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $25,680 - $33,756	-355 Reduced 0.68%	51,581 $4.37 Million
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $2.13 Million - $2.85 Million	27,166 Added 109.67%	51,936 $4.14 Million
Q2 2021 Aug 11, 2021	BUY	$97.2 - $137.59 $143,467 - $203,082	1,476 Added 6.34%	24,770 $2.41 Million
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $1.18 Million - $1.36 Million	-10,876 Reduced 31.83%	23,294 $2.73 Million
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $1.95 Million - $2.37 Million	-17,756 Reduced 34.19%	34,170 $3.8 Million
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $4.33 Million - $5.39 Million	43,415 Added 510.1%	51,926 $6.17 Million
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $4.45 Million - $9.31 Million	-74,024 Reduced 89.69%	8,511 $964,000
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $1.68 Million - $2.36 Million	25,198 Added 43.95%	82,535 $5.51 Million
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $3.51 Million - $4.94 Million	41,677 Added 266.14%	57,337 $5.22 Million
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $3.06 Million - $3.87 Million	-36,289 Reduced 69.86%	15,660 $1.35 Million
Q2 2019 Aug 16, 2019	BUY	$91.13 - $142.5 $607,745 - $950,332	6,669 Added 14.73%	51,949 $5.45 Million
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $1.18 Million - $1.85 Million	-13,003 Reduced 22.31%	45,280 $4.75 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $4.66 Million - $6.47 Million	45,008 Added 339.04%	58,283 $7.3 Million
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $1.26 Million - $2.86 Million	13,275 New	13,275 $1.5 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Madrigal Pharmaceuticals, Inc. Transaction History